In RA, early endothelial dysfunction is driven by inflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin (IL)−1, and is reflected by increased C-reactive protein (CRP). This evidence concerns the gene CRP and endothelial dysfunction.